Lung Diseases

Cellular Therapy Can Help.

lung-diseases

Lung Diseases Treated with Cellular Therapy

The Lung Institute treats a number of both restrictive and obstructive lung diseases. Since opening our doors in 2013, we’ve treated over 4,000 patients, and many patients have reported seeing an increase in their quality of life.

At the Lung Institute, we provide cellular therapy for the following lung diseases:

 

 

 

 

 

 

Click on the links above to learn more about these specific diseases. It doesn’t matter if you’ve just been diagnosed, or suffering for years. The natural healing properties of cells are beneficial to patients during any stage of their disease.

Treatment Options

All treatments performed at the Lung Institute are outpatient procedures. As a result, our treatments are considered extremely safe. Our therapies are minimally invasive and performed over the course of 2 days.
We offer:


Lung Institute
Blood -Derived Treatment

Want to Know More?

See what our patients are saying about their experience receiving cell therapy for lung disease.


If you have questions about your candidacy for treatment, please contact one of our patient coordinators today. They are very helpful in explaining the treatment process. If you would like to find out more about our available treatment options, please call us today at (800) 729-3065 to schedule a free consultation.

Related Posts

  • Pulmonary fibrosis causes scar tissue to form in the lungs’ air sacs, making it more difficult for the lungs to deliver oxygen to the bloodstream. A type of interstitial lung ... Read more
  • Chronic obstructive pulmonary disease (COPD), a chronic lung disease characterized by shortness of breath, wheezing, chest tightness and constant coughing, can feel like a death sentence to many. For those ... Read more

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.